Medtech grants in Denmark

Closed

Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.

Closed

Awards EU deep-tech teams up to €2.5 million in lump-sum grants across two stages.

Closed

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Closed

Funds clinical validation and regulatory approval for AI-enabled medical devices reaching market readiness.

Closed

Offers research teams and institutions for EIT Health New Models to Deliver Healthcare in medical technology and artificial intelligence.

Closed

Supports pre acceleration programme with prizes and mentorship for early stage healthcare innovators across Europe.

Closed

Pays the existing EU Personalised Medicine partnership to bring in new partners and additional activities under an amended grant agreement.

Closed

Funds research teams that use gene and epigenome editing to engineer safer, more effective off-the-shelf cell therapies for one chosen disease area.

Closed

Funds coordination projects that scale up validated digital health and AI tools across national or sub-regional health systems in sub-Saharan Africa.

Closed

Pays one coordination team to run the EU-wide policy forum that gets governments, regulators and industry to agree on which animal-testing-alternative methods are ready for official use.

Closed

Funds investigator-led frontier research across disciplines, enabling high-risk discovery with strong scientific autonomy.

Closed

Funds frontier research by established researchers in Europe-backed programmes across any discipline with high-risk, high-impact ambitions.

Closed

Funds existing ERC grant holders in testing the commercial or societal potential of already-funded research through a fixed EUR 150,000 top-up grant.

Closed

Funds one project to build the infrastructure, training and digital tools needed to run same-day orthopaedic and cardiology surgical centres in Europe.

Closed

Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.

Closed

Supports international consortia so small companies can turn joint innovation into export-ready products.

Closed

Funds the coordination of up to ten existing advanced-therapy research centres into one European network, with a shared roadmap for scaling up gene and cell therapy manufacturing.

Closed

Funds industrial production of stable isotopes needed for radionuclide therapies and a more resilient European medical supply chain.

Closed

Funds a pan-European network of 10-18 startup and scaleup hubs that can pass on up to EUR 60,000 per deep-tech startup for cross-border scaling support.

Closed

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Closed

Funds the next development stage, TRL 5 and up, for regenerative-medicine results that already came out of an earlier, completed EU-funded research project.

Closed

Funds implementation research that tests how schools, workplaces and other non-health settings can help prevent or manage chronic disease in low- and middle-income countries and underserved communities.

Closed

Funds around two research projects, each worth EUR 1 to 2 million, to adapt EU-built generative AI to African challenges in farming, health, cities and education.

Closed

Funds consortia that build or adapt generative AI models on large-scale multimodal health data and prove their value with at least two real biomedical use cases.